• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

老年受试者的糖耐量受损和糖尿病

Impaired glucose tolerance and diabetes mellitus in elderly subjects.

作者信息

Agner E, Thorsteinsson B, Eriksen M

出版信息

Diabetes Care. 1982 Nov-Dec;5(6):600-4. doi: 10.2337/diacare.5.6.600.

DOI:10.2337/diacare.5.6.600
PMID:6927730
Abstract

In a 10-yr prospective population study 406 subjects who were 70 yr old received an oral glucose tolerance test. Of these subjects 169 were retested at 80. Three sets of diagnostic criteria were evaluated, of which the WHO criteria are recommended for screening studies in this age group. The prevalences of diabetes mellitus (DM) and impaired glucose tolerance (IGT) according to the latter criteria were 10% and 26% at 70 and 12% and 35% at 80 in men and women. Excess 10-yr mortality was seen in both sexes when DM existed at 70, and in men also when IGT existed at this age. The excess mortality in men could solely--and in women partly--be explained by cardiovascular diseases. The 10-yr incidence of DM was 20% if IGT existed at 70, but only 4% when normal glucose tolerance was present at 70.

摘要

在一项为期10年的前瞻性人群研究中,406名70岁的受试者接受了口服葡萄糖耐量试验。其中169人在80岁时再次接受测试。评估了三组诊断标准,其中世界卫生组织(WHO)标准推荐用于该年龄组的筛查研究。根据后一种标准,男性和女性在70岁时糖尿病(DM)和糖耐量受损(IGT)的患病率分别为10%和26%,在80岁时分别为12%和35%。当70岁时患有DM时,男女两性均出现10年超额死亡率,当该年龄患有IGT时,男性也出现超额死亡率。男性的超额死亡率完全可以——女性部分可以——由心血管疾病解释。如果70岁时存在IGT,DM的10年发病率为20%,但70岁时葡萄糖耐量正常时仅为4%。

相似文献

1
Impaired glucose tolerance and diabetes mellitus in elderly subjects.老年受试者的糖耐量受损和糖尿病
Diabetes Care. 1982 Nov-Dec;5(6):600-4. doi: 10.2337/diacare.5.6.600.
2
[Prevalence of type II diabetes mellitus in population of Krakow].[克拉科夫人群中2型糖尿病的患病率]
Pol Arch Med Wewn. 2001 Sep;106(3):771-9.
3
Diabetes and impaired glucose tolerance prevalences in Turkish patients with impaired fasting glucose.空腹血糖受损的土耳其患者中糖尿病和糖耐量受损的患病率
Acta Diabetol. 2008 Sep;45(3):151-6. doi: 10.1007/s00592-008-0034-y. Epub 2008 May 22.
4
[Prevalence of newly diagnosed type 2 diabetes, impaired glucose tolerance and abnormal fasting glucose in a high risk population. Data from the RIAD study using new diagnostic criteria for diabetes].[高危人群中新诊断2型糖尿病、糖耐量受损及空腹血糖异常的患病率。来自采用糖尿病新诊断标准的RIAD研究的数据]
Dtsch Med Wochenschr. 1999 Sep 17;124(37):1057-61. doi: 10.1055/s-2007-1024481.
5
Prevalence of diabetes and impaired glucose tolerance in elderly subjects and their association with obesity and family history of diabetes.老年人群中糖尿病和糖耐量受损的患病率及其与肥胖和糖尿病家族史的关联。
Diabetes Care. 1990 Nov;13(11):1099-105. doi: 10.2337/diacare.13.11.1099.
6
Evaluation of insulin release and insulin sensitivity through oral glucose tolerance test: differences between NGT, IFG, IGT, and type 2 diabetes mellitus. A cross-sectional and follow-up study.通过口服葡萄糖耐量试验评估胰岛素释放和胰岛素敏感性:正常糖耐量、空腹血糖受损、糖耐量受损和2型糖尿病之间的差异。一项横断面和随访研究。
Acta Diabetol. 2004 Jun;41(2):70-6. doi: 10.1007/s00592-004-0147-x.
7
Screening for noninsulin dependent diabetes mellitus and impaired glucose tolerance in a Dunedin general practice--is it worth it?在达尼丁一家普通诊所筛查非胰岛素依赖型糖尿病和糖耐量受损——这值得吗?
N Z Med J. 1992 Jun 10;105(935):208-10.
8
Comparison of Insulin Resistance and β-Cell Dysfunction Between the Young and the Elderly in Normal Glucose Tolerance and Prediabetes Population: A Prospective Study.正常糖耐量和糖尿病前期人群中年轻人与老年人胰岛素抵抗和β细胞功能障碍的比较:一项前瞻性研究
Horm Metab Res. 2017 Feb;49(2):135-141. doi: 10.1055/s-0042-111325. Epub 2016 Jul 26.
9
Tissue factor pathway inhibitor and other endothelium-dependent hemostatic factors in elderly individuals with normal or impaired glucose tolerance and type 2 diabetes.糖耐量正常、糖耐量受损及2型糖尿病老年个体中的组织因子途径抑制物及其他内皮依赖性止血因子
Diabetes Care. 2002 Aug;25(8):1340-5. doi: 10.2337/diacare.25.8.1340.
10
[Appearance of undiagnosed diabetes mellitus in the population of professionally active people in the urban areas].[城市职业人群中未诊断出的糖尿病的出现情况]
Pol Arch Med Wewn. 2001 Sep;106(3):815-21.

引用本文的文献

1
Prevalence of Type 2 Diabetes Mellitus among Urban Sikh Population of Amritsar.阿姆利则城市锡克教人群中2型糖尿病的患病率
Indian J Community Med. 2016 Oct-Dec;41(4):263-267. doi: 10.4103/0970-0218.193338.
2
Prevalence of type 2 diabetes mellitus in elderly in a primary care facility: An ideal facility.基层医疗设施中老年人2型糖尿病的患病率:一个理想的设施。
Indian J Endocrinol Metab. 2013 Oct;17(Suppl 1):S318-22. doi: 10.4103/2230-8210.119647.
3
Cardiovascular disease risk factors as predictors of type 2 (non-insulin-dependent) diabetes mellitus in elderly subjects.
心血管疾病危险因素作为老年受试者2型(非胰岛素依赖型)糖尿病的预测指标。
Diabetologia. 1993 Jun;36(6):553-9. doi: 10.1007/BF02743273.
4
Prevalence of diabetes mellitus in elderly men aged 65 to 84 years in eastern and western Finland.芬兰东部和西部65至84岁老年男性糖尿病患病率。
Diabetologia. 1986 Sep;29(9):611-5. doi: 10.1007/BF00869258.
5
Is the common presence of glucose intolerance in old age a reliable index for the subsequent occurrence of fasting hyperglycemia?老年人中普遍存在的葡萄糖耐量异常是否是随后发生空腹血糖过高的可靠指标?
Acta Diabetol Lat. 1986 Jan-Mar;23(1):57-61. doi: 10.1007/BF02581355.
6
The prevalence of diabetes mellitus and an assessment of methods of detection among a community of elderly Chinese in Hong Kong.香港老年华人社区中糖尿病的患病率及检测方法评估。
Diabetologia. 1987 Nov;30(11):863-8. doi: 10.1007/BF00274795.
7
Transient impaired glucose tolerance in Pima Indians: is it important?皮马印第安人的短暂性糖耐量受损:这重要吗?
BMJ. 1988 Dec 3;297(6661):1438-41. doi: 10.1136/bmj.297.6661.1438.
8
Impaired glucose tolerance in a middle-aged male urban population: a new approach for identifying high-risk cases.
Diabetologia. 1990 Sep;33(9):526-31. doi: 10.1007/BF00404139.
9
Diabetes in the elderly: remarks from an epidemiological study carried out in a town in south-eastern Sicily (Militello V.C.).
Acta Diabetol Lat. 1990 Jul-Sep;27(3):231-42. doi: 10.1007/BF02581335.
10
Acute effect of glipizide on glucose tolerance in obesity and diabetes mellitus (NIDDM).
Eur J Clin Pharmacol. 1991;40(1):23-6. doi: 10.1007/BF00315134.